suggest that patients with a type of blood cancer called chronic lymphocytic leukemia (CLL) who are being treated with Bruton ...

During a live event, Daniel M. Geynisman, MD, and participants discussed their answers to a poll on which combination to use ...

A common malaria drug could be repurposed to treat a variety of hematologic cancers and solid tumors, according to early ...

Cabometyx is one of the leading tyrosine kinase inhibitor (TKI ... with locally advanced or metastatic differentiated thyroid cancer (DTC) that has progressed following prior VEGFR-targeted ...

There were a number of notable developments for patients with kidney cancer at the symposium, Dr. Emre Yekedüz explained.

Bristol Myers Squibb has received the FDA’s green light to introduce another immunotherapy-based treatment in first-line ...

The phosphoinositide 3-kinase (PI3K) pathway is a crucial signal ... the most frequently activated signalling pathways in human cancer. Oncogenic activation of this pathway commonly occurs through ...